US Stock MarketDetailed Quotes

BLRX BioLine Rx

Watchlist

0.256
+0.042+19.44%

Close Jan 2 16:00 ET

0.363
+0.107+42.02%

Pre 07:00 ET

21.50MMarket Cap-0.85P/E (TTM)

BioLine Rx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

0.77%-9.83M

-17.01%-11.33M

-76.01%-14.11M

13.84%-22.61M

187.98%4.99M

-13.91%-9.9M

-53.95%-9.68M

-43.50%-8.02M

-11.31%-26.24M

-3.09%-5.67M

Net income from continuing operations

63.66%-5.82M

102.61%484K

94.28%-696K

-142.93%-60.61M

-142.26%-13.88M

-134.01%-16.02M

-149.16%-18.55M

-146.69%-12.16M

7.77%-24.95M

-33.16%-5.73M

Operating gains losses

-108.98%-283K

-198.13%-7.92M

-248.39%-4.52M

291.38%11.24M

15.66%-3.03M

425.75%3.15M

6,604.84%8.07M

355.54%3.05M

-429.09%-5.87M

-53.33%-3.59M

Depreciation and amortization

280.09%840K

140.40%476K

246.33%897K

111.62%1.38M

277.54%706K

44.44%221K

40.43%198K

49.71%259K

-6.97%654K

7.47%187K

Other non cash items

-230.06%-1.45M

125.33%2.39M

236.09%447K

161.35%1.16M

-200.18%-1.14M

278.62%1.11M

11,900.00%1.06M

304.62%133K

1,041.03%445K

5,533.33%1.14M

Change In working capital

-394.01%-3.43M

-659.92%-7.2M

-4,045.05%-10.77M

1,127.71%15.2M

1,064.37%14.71M

215.30%1.17M

-216.18%-948K

58.72%273K

329.26%1.24M

111.56%1.26M

-Change in receivables

---432K

---347K

---2.47M

---358K

--0

----

-Change in inventory

106.66%90K

---745K

---936K

---1.95M

---601K

---1.35M

--0

-Change in prepaid assets

82.65%716K

47.43%-440K

166.94%81K

-47.54%-959K

-64.44%-393K

41.52%392K

-38.12%-837K

-47.56%-121K

-2,808.33%-650K

-164.25%-239K

-Change in payables and accrued expense

-127.54%-586K

-1,811.71%-2.12M

-991.12%-3.51M

191.95%5.51M

106.46%3.1M

264.96%2.13M

-107.81%-111K

55.12%394K

434.75%1.89M

567.56%1.5M

-Change in other working capital

---3.22M

---3.55M

---3.93M

--12.96M

----

Cash from discontinued investing activities

Operating cash flow

0.77%-9.83M

-17.01%-11.33M

-76.01%-14.11M

13.84%-22.61M

187.82%4.99M

-14.04%-9.9M

-53.95%-9.68M

-43.50%-8.02M

-11.31%-26.24M

-3.27%-5.68M

Investing cash flow

Cash flow from continuing investing activities

148.35%10.18M

-177.88%-8.65M

151.23%16.69M

-63.95%1.44M

-628.09%-20.4M

127.43%4.1M

10.66%11.1M

31.58%6.64M

110.48%4.01M

-3.40%3.86M

Net PPE purchase and sale

--0

59.70%-27K

0.00%-32K

11.45%-116K

71.93%-16K

91.67%-1K

-52.27%-67K

-77.78%-32K

-35.05%-131K

41.24%-57K

Net intangibles purchase and sale

--0

2.16%-181K

98.83%-2K

-85.71%-26K

---56K

---97K

---185K

-588.57%-171K

Net investment purchase and sale

146.73%10.18M

-176.79%-8.62M

146.92%16.72M

-59.72%1.74M

-598.22%-20.38M

127.66%4.12M

11.39%11.22M

33.66%6.77M

111.34%4.32M

0.74%4.09M

Cash from discontinued investing activities

Investing cash flow

148.35%10.18M

-177.88%-8.65M

151.23%16.69M

-63.95%1.44M

-628.09%-20.4M

127.43%4.1M

10.66%11.1M

31.58%6.64M

110.48%4.01M

-3.40%3.86M

Financing cash flow

Cash flow from continuing financing activities

-134.81%-1.22M

17,920.15%23.88M

-1,724.49%-894K

-26.33%15.06M

1,914.53%11.74M

-84.60%3.5M

80.55%-134K

94.80%-49K

-64.61%20.44M

-471.84%-647K

Net issuance payments of debt

-10.19%-1.04M

13,767.16%18.31M

-1,724.49%-894K

-132.73%-1.99M

-32.77%-863K

-110.92%-942K

86.00%-134K

94.80%-49K

270.04%6.07M

29.73%-650K

Net common stock issuance

-110.92%-207K

----

-1.88%14.09M

--12.19M

-86.55%1.9M

----

-71.51%14.36M

--0

Proceeds from stock option exercised by employees

----

59,000.00%2.96M

13,566.67%410K

----

-99.95%5K

--3K

Cash from discontinued financing activities

Financing cash flow

-134.81%-1.22M

17,920.15%23.88M

-1,724.49%-894K

-26.33%15.06M

1,914.53%11.74M

-84.60%3.5M

80.55%-134K

94.80%-49K

-64.61%20.44M

-471.84%-647K

Net cash flow

Beginning cash position

-4.76%9.62M

-33.93%5.99M

-59.81%4.26M

-18.50%10.59M

-41.04%7.73M

-27.83%10.1M

-20.79%9.07M

-18.50%10.59M

-22.82%12.99M

-6.90%13.11M

Current changes in cash

62.34%-868K

204.13%3.91M

218.34%1.68M

-240.09%-6.11M

-48.46%-3.66M

-156.11%-2.31M

-57.94%1.28M

3.92%-1.42M

55.63%-1.8M

-85.42%-2.47M

Effect of exchange rate changes

212.50%81K

-10.57%-272K

152.04%51K

63.10%-224K

484.00%192K

-1,540.00%-72K

50.70%-246K

-55.56%-98K

-393.24%-607K

-120.49%-50K

End cash Position

14.35%8.84M

-4.76%9.62M

-33.93%5.99M

-59.81%4.26M

-41.04%7.73M

-27.83%10.1M

-20.79%9.07M

-18.50%10.59M

Free cash flow

1.04%-9.83M

-15.82%-11.36M

-73.62%-14.14M

13.75%-22.91M

184.13%4.97M

-14.01%-9.93M

-54.82%-9.81M

-45.34%-8.15M

-12.19%-26.56M

-6.22%-5.91M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	0.77%-9.83M	-17.01%-11.33M	-76.01%-14.11M	13.84%-22.61M	187.98%4.99M	-13.91%-9.9M	-53.95%-9.68M	-43.50%-8.02M	-11.31%-26.24M	-3.09%-5.67M
Net income from continuing operations	63.66%-5.82M	102.61%484K	94.28%-696K	-142.93%-60.61M	-142.26%-13.88M	-134.01%-16.02M	-149.16%-18.55M	-146.69%-12.16M	7.77%-24.95M	-33.16%-5.73M
Operating gains losses	-108.98%-283K	-198.13%-7.92M	-248.39%-4.52M	291.38%11.24M	15.66%-3.03M	425.75%3.15M	6,604.84%8.07M	355.54%3.05M	-429.09%-5.87M	-53.33%-3.59M
Depreciation and amortization	280.09%840K	140.40%476K	246.33%897K	111.62%1.38M	277.54%706K	44.44%221K	40.43%198K	49.71%259K	-6.97%654K	7.47%187K
Other non cash items	-230.06%-1.45M	125.33%2.39M	236.09%447K	161.35%1.16M	-200.18%-1.14M	278.62%1.11M	11,900.00%1.06M	304.62%133K	1,041.03%445K	5,533.33%1.14M
Change In working capital	-394.01%-3.43M	-659.92%-7.2M	-4,045.05%-10.77M	1,127.71%15.2M	1,064.37%14.71M	215.30%1.17M	-216.18%-948K	58.72%273K	329.26%1.24M	111.56%1.26M
-Change in receivables	---432K	---347K	---2.47M	---358K	---358K	--0	--0	--0	--0	----
-Change in inventory	106.66%90K	---745K	---936K	---1.95M	---601K	---1.35M	--0	--0	--0	--0
-Change in prepaid assets	82.65%716K	47.43%-440K	166.94%81K	-47.54%-959K	-64.44%-393K	41.52%392K	-38.12%-837K	-47.56%-121K	-2,808.33%-650K	-164.25%-239K
-Change in payables and accrued expense	-127.54%-586K	-1,811.71%-2.12M	-991.12%-3.51M	191.95%5.51M	106.46%3.1M	264.96%2.13M	-107.81%-111K	55.12%394K	434.75%1.89M	567.56%1.5M
-Change in other working capital	---3.22M	---3.55M	---3.93M	--12.96M	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	0.77%-9.83M	-17.01%-11.33M	-76.01%-14.11M	13.84%-22.61M	187.82%4.99M	-14.04%-9.9M	-53.95%-9.68M	-43.50%-8.02M	-11.31%-26.24M	-3.27%-5.68M
Investing cash flow
Cash flow from continuing investing activities	148.35%10.18M	-177.88%-8.65M	151.23%16.69M	-63.95%1.44M	-628.09%-20.4M	127.43%4.1M	10.66%11.1M	31.58%6.64M	110.48%4.01M	-3.40%3.86M
Net PPE purchase and sale	--0	59.70%-27K	0.00%-32K	11.45%-116K	71.93%-16K	91.67%-1K	-52.27%-67K	-77.78%-32K	-35.05%-131K	41.24%-57K
Net intangibles purchase and sale	--0	--0	--0	2.16%-181K	98.83%-2K	-85.71%-26K	---56K	---97K	---185K	-588.57%-171K
Net investment purchase and sale	146.73%10.18M	-176.79%-8.62M	146.92%16.72M	-59.72%1.74M	-598.22%-20.38M	127.66%4.12M	11.39%11.22M	33.66%6.77M	111.34%4.32M	0.74%4.09M
Cash from discontinued investing activities
Investing cash flow	148.35%10.18M	-177.88%-8.65M	151.23%16.69M	-63.95%1.44M	-628.09%-20.4M	127.43%4.1M	10.66%11.1M	31.58%6.64M	110.48%4.01M	-3.40%3.86M
Financing cash flow
Cash flow from continuing financing activities	-134.81%-1.22M	17,920.15%23.88M	-1,724.49%-894K	-26.33%15.06M	1,914.53%11.74M	-84.60%3.5M	80.55%-134K	94.80%-49K	-64.61%20.44M	-471.84%-647K
Net issuance payments of debt	-10.19%-1.04M	13,767.16%18.31M	-1,724.49%-894K	-132.73%-1.99M	-32.77%-863K	-110.92%-942K	86.00%-134K	94.80%-49K	270.04%6.07M	29.73%-650K
Net common stock issuance	-110.92%-207K	----	----	-1.88%14.09M	--12.19M	-86.55%1.9M	----	----	-71.51%14.36M	--0
Proceeds from stock option exercised by employees	----	----	----	59,000.00%2.96M	13,566.67%410K	----	----	----	-99.95%5K	--3K
Cash from discontinued financing activities
Financing cash flow	-134.81%-1.22M	17,920.15%23.88M	-1,724.49%-894K	-26.33%15.06M	1,914.53%11.74M	-84.60%3.5M	80.55%-134K	94.80%-49K	-64.61%20.44M	-471.84%-647K
Net cash flow
Beginning cash position	-4.76%9.62M	-33.93%5.99M	-59.81%4.26M	-18.50%10.59M	-41.04%7.73M	-27.83%10.1M	-20.79%9.07M	-18.50%10.59M	-22.82%12.99M	-6.90%13.11M
Current changes in cash	62.34%-868K	204.13%3.91M	218.34%1.68M	-240.09%-6.11M	-48.46%-3.66M	-156.11%-2.31M	-57.94%1.28M	3.92%-1.42M	55.63%-1.8M	-85.42%-2.47M
Effect of exchange rate changes	212.50%81K	-10.57%-272K	152.04%51K	63.10%-224K	484.00%192K	-1,540.00%-72K	50.70%-246K	-55.56%-98K	-393.24%-607K	-120.49%-50K
End cash Position	14.35%8.84M	-4.76%9.62M	-33.93%5.99M	-59.81%4.26M	-59.81%4.26M	-41.04%7.73M	-27.83%10.1M	-20.79%9.07M	-18.50%10.59M	-18.50%10.59M
Free cash flow	1.04%-9.83M	-15.82%-11.36M	-73.62%-14.14M	13.75%-22.91M	184.13%4.97M	-14.01%-9.93M	-54.82%-9.81M	-45.34%-8.15M	-12.19%-26.56M	-6.22%-5.91M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Heat List

Overall

No Data